KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nu Skin Enterprises (NUS) Invested Capital (2016 - 2025)

Nu Skin Enterprises' Invested Capital history spans 17 years, with the latest figure at $825.2 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 21.1% year-over-year to $825.2 million; the TTM value through Dec 2025 reached $825.2 million, up 21.1%, while the annual FY2025 figure was $825.2 million, 21.1% up from the prior year.
  • Invested Capital for Q4 2025 was $825.2 million at Nu Skin Enterprises, up from $819.8 million in the prior quarter.
  • Across five years, Invested Capital topped out at $1.1 billion in Q2 2021 and bottomed at $681.5 million in Q4 2024.
  • The 5-year median for Invested Capital is $903.4 million (2022), against an average of $898.1 million.
  • The largest annual shift saw Invested Capital increased 22.04% in 2021 before it tumbled 30.83% in 2024.
  • A 5-year view of Invested Capital shows it stood at $1.0 billion in 2021, then decreased by 9.6% to $922.3 million in 2022, then fell by 8.17% to $847.0 million in 2023, then dropped by 19.54% to $681.5 million in 2024, then increased by 21.1% to $825.2 million in 2025.
  • Per Business Quant, the three most recent readings for NUS's Invested Capital are $825.2 million (Q4 2025), $819.8 million (Q3 2025), and $822.8 million (Q2 2025).